Prohibited List

The list of banned substances and methods (Prohibited List) is usually published annually by the World Anti-Doping Agency (WADA) and enters into force on 1st January of each year. The Prohibited List is one of WADA's six International Standards, the implementation of which is mandatory for all signatories of the World Anti-Doping Programme.
 
It is the responsibility of all athletes to ensure that they consult the currently valid Prohibited List and find out about the specific regulations of their authority.
 
Every year Antidoping Switzerland publishes the Prohibited List that applies to Switzerland in German and French. A printed version of this list may be obtained free of charge from Antidoping Switzerland.
 
In addition to the Prohibited List, a list is available of permitted, non-prescription medicines and drugs for the treatment of common illnesses in Switzerland. In order to avoid unintentional doping violations with medicine, it is recommended to consult the practical drugs enquiry Global DRO.

New from 2019: changes to the Prohibited List

The 2019 Prohibited List enters into force on 1 January 2019 and immediately replaces all previous lists. The World Anti-Doping Agency has made only formal changes to the 2019 Prohibited List. In practice, this means that all substances and methods that were banned in 2018 remain banned in 2019. 

Antidoping Switzerland now makes the translated list available as a pdf in two separate versions: German and French. 

New from 2018: Modifications of the Prohibited List

The 2018 List of Prohibited Substances is valid from 1 January 2018 and replaces all other previous lists. The most important changes are commented on below and a summary of modifications is available on the WADA website (see Links). There are no practicable changes concerning over-the-counter medications.

S3 Beta-2-Agonists

The 2018 list mentions the most common prohibited beta-2-agonists and Tulobuterol was added as an example. Hoewever, Salbutamol, Formoterol and Salmeterol are permitted to treat asthma by inhalation up to a fixed maximum dose. As long as this daily dosage is respected, no therapeutic use exemption (TUE) is required to take these substances by inhalation. WADA clarified that, the 12-hour period for Salbutamol is starting from any dose.

If the dose needs to be increased for medical reasons or another beta-2-agonist is needed in asthma treatment, a TUE is required. Pool athletes must apply for a TUE prior to starting a prohibited therapy, except in case of an emergency treatment.

M2 Chemical and physical manipulation

An important change for the medical practice occurred with the increase of the allowed volume for intravenous injections/infusions from 50ml per 6-hour period to 100 ml per 12-hour period starting from 1 January 2018. This eases the discussion about the use of iron injections in athletes.

S8 Cannabinoids

Unlike all other cannabinoids, pure Cannabidiol (CBD) is no longer prohibited in sport. However, the CBD products available in Switzerland contain a certain proportion of tetrahydrocannabinol (THC) which is prohibited in competition. Therefore, Antidoping Switzerland still recommends to refrain from using cannabis products, including CBD products, as a precautionary measure.